Equities
Top Premarket Decliners
STAK (STAK) shares were down 55% in Monday premarket trading after the earlier session's 602% rally.MapLight Therapeutics (MPLT) stock was down 55% after the company said a phase 2 trial of ML-007C-MA in schizophrenia met its primary endpoint, demonstrating a significant reduction in severity of the condition versus placebo.Profusa (PFSA) shares were down 18% after the company signed a non-binding term sheet to acquire a privately held commercial-stage diagnostics and toxicology testing company.Recon Technology (RCON) stock was down 15%, following the earlier session's 11.6% gain.
$MPLT$PFSA$RCON$STAK
